Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). (Q43885601)

From Wikidata
Jump to navigation Jump to search
scientific article published in December 2001
edit
Language Label Description Also known as
English
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).
scientific article published in December 2001

    Statements

    Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). (English)
    European Organization for Research and Treatment of Cancer (EORTC)
    Leukaemia Cooperative Group (LCG)
    Dutch Haemato-Oncology Cooperative Study Group (HOVON)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit